← Back to patent-cliff list
CAS 10310-21-1
6-chloro-9H-purin-2-amine
Codes: NELA-001
Application context (from source-drug indications)
T-lymphoblastic lymphoma/leukaemiaNelarabineSézary syndromeNelarabineMarginal zone B-cell lymphomaNelarabineAdult T-cell leukaemia/lymphomaNelarabineWaldenström macroglobulinaemiaNelarabineLymphomaNelarabine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Nelarabine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6-chloro-9H-purin-2-amine→6-methoxy-9H-purin-2-amine→(R)-3-((2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridine-2,6(1H,3H)-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.